9 Results

People

  1. Korde
    Korde
  2. Landgren
    Landgren
  3. Mailankody
    Mailankody
  4. Hassoun
    Hassoun
  5. Hultcrantz
    Hultcrantz
  6. Lesokhin
    Lesokhin
  7. Chung
    Chung
  8. Giralt
    Giralt
  9. Lahoud
    Lahoud
  10. Landau
    Landau

Groups

  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies Research (9)
  4. Hematologic Malignancies, Division of (9)
  5. Myeloma (9)
  6. Survivorship Research (9)
  7. Sloan Kettering Institute Postdocs (5)
  8. CTCR Scholars (4)
  9. Bone Marrow Transplant (3)
  10. Epidemiology and Biostatistics (3)
  1. "minimal residual disease"
  2. "Neha Korde"
  3. "Carl Landgren"
Formats
  1. Journal Article (7)
  2. Conference Paper (1)
  3. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies Research (9)
  4. Hematologic Malignancies, Division of (9)
  5. Myeloma (9)
  6. Survivorship Research (9)

More Groups

People
  1. Carl Landgren (9)
  2. Neha Korde (9)
  3. Sham Mailankody (6)
  4. Alexander Lesokhin (5)
  5. Hani Hassoun (5)
  6. Malin Hultcrantz (5)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (2)
  4. 2017 (1)
  5. 2015 (2)
  6. 2014 (1)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (2)
  2. JAMA Oncology (2)
  3. American Journal of Hematology (1)
  4. Biology of Blood and Marrow Transplantation (1)
  5. British Journal of Haematology (1)
  6. Cancer Chemotherapy and Pharmacology (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. American Medical Association (2)
  3. John Wiley & Sons (1)
  4. John Wiley & Sons, Inc. (1)
  5. Nature Publishing Group (1)
  6. Springer (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
    Journal Article

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Lu, S.; Shah, U.; Hassoun, H.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms
    Journal Article

    Sissung, T. M.; Peer, C. J.; Korde, N.; Mailankody, S.; Kazandjian, D.; Venzon, D. J.; Landgren, O.; Figg, W. D.
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma
    Journal Article

    Korde, N.; Roschewski, M.; Zingone, A.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Mailankody, S.; Wu, P.; more...
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Minimal residual disease in multiple myeloma: Bringing the bench to the bedside
    Journal Article

    Mailankody, S.; Korde, N.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Stetler-Stevenson, M.; Landgren, O.
    Nature Reviews Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The road to treating smoldering multiple myeloma
    Conference Paper

    Korde, N.; Mailankody, S.; Landgren, O.
    Elsevier Inc. (2014)

    Fulltext@MSK | Save